The Role of Mobility Endpoints in Marketing Authorisation of Drugs: What Gets the EMA Moving?
暂无分享,去创建一个
C. Becker | J. Klenk | L. Leocani | B. Sharrack | M. Puhan | D. Schoene | L. Rochester | J. Garcia-Aymerich | W. Maetzler | M. Schwab | Michael Chambers | S. Corriol‐Rohou | R. Tremmel | S. Jaeger | Martin Wohlrab